Neurofibrillary lesions correlate strongly with cognitive deficits, making them an important therapeutic target for Alzheimer's disease 1 . Dominantly inherited mutations in MAPT, which encodes tau protein, cause frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17T), showing that dysfunction of tau is sufficient to cause neurodegeneration and dementia 2 . Ultrastructurally, tau inclusions are made of paired helical filaments (PHFs) and straight filaments (SFs) [3] [4] [5] . Negative-stain electron microscopy shows that the cores of PHFs and SFs consist of a double helical stack of C-shaped subunits 6 , whereas the amino-and carboxy-terminal regions of tau are disordered and project away from the core to form the fuzzy coat 7 . In Alzheimer's disease, tau filaments form from full-length tau in cells, but have lost most of their fuzzy coat in extracellular ghost tangles. They have a cross-β structure 8 . Neurofibrillary lesions appear to propagate in the course of Alzheimer's disease through connected pathways, from subcortical areas to the transentorhinal cortex, limbic system and neocortex 9 . Although the molecular tau species responsible for neurodegeneration are unknown, short filaments are the main species of seed-competent tau in the brains of transgenic mice expressing human P301S tau 10 . Six tau isoforms ranging from 352 to 441 amino acids in length are expressed in the adult human brain; these are produced by alternative mRNA splicing of transcripts from MAPT 11 . They differ in the presence or absence of inserts of 29 or 58 amino acids in the N-terminal half, and the inclusion or absence of the 31-amino-acid microtubule-binding repeat, encoded by exon 10 of MAPT, in the C-terminal half. Inclusion of exon 10 results in the production of three tau isoforms with four repeats each (4R), and its exclusion in a further three isoforms with three repeats each (3R). The four repeats (R1-R4) comprise residues 244-368 in the 441-amino-acid tau isoform.
Neurodegenerative diseases with abundant filamentous tau inclusions are referred to as tauopathies 2 . Besides Alzheimer's disease, these diseases include tangle-only dementia, chronic traumatic encephalopathy, argyrophilic grain disease, progressive supranuclear palsy, corticobasal degeneration, globular glial tauopathy and Pick's disease. Unlike Alzheimer's disease, these other diseases lack amyloid-β plaques. In Alzheimer's disease, tangle-only dementia and chronic traumatic encephalopathy, all six tau isoforms (3R and 4R) are present in the disease filaments. In argyrophilic grain disease, progressive supranuclear palsy, corticobasal degeneration and globular glial tauopathy, only 4R tau isoforms are found, whereas in Pick's disease only 3R tau inclusions are present. The occurence of human tauopathies with distinct filament morphologies 12 has led to the idea that different molecular conformers of aggregated tau exist. The occurence of multiple molecular conformers might also explain why filaments from the brains of individuals with Alzheimer's are more effective than in vitro assembled filaments of recombinant protein in inducing tau pathology in mouse brain 13 . Progress in understanding tauopathies is hampered by the lack of atomic structures of tau filaments from brain samples. Studies of amyloids have been complicated by potential differences in structure between filaments in the brain and those assembled in vitro. Lowresolution cryo-EM structures of in vitro assembled filaments of amyloid-β are available 14 , and solid-state NMR has been used to study the structures of recombinant amyloid-β [15] [16] [17] and α -synuclein 18 . Even when seeding in vitro filament growth with extracts from diseased brains 16, 18 , structures may not be amplified according to their relative abundance in the brain. Here, we present atomic models, as determined by cryo-EM, for the core of PHFs and SFs that were purified from the brain of an individual with Alzheimer's disease.
article reSearcH died at the age of 86 years with a 16-year history of Alzheimer's disease. Thioflavin S staining showed the presence of abundant neurofibrillary tangles and neuritic plaques in cerebral cortex (Fig. 1b) . The sarkosylinsoluble fraction of the patient's neocortex contained numerous PHFs and SFs, which were composed of full-length, hyperphosphorylated tau, as assessed by immuno-gold EM (Extended Data Fig. 1 ). Negatively stained PHFs had a longitudinal spacing between crossovers of 650-800 Å and a width of about 150 Å at the widest part and 70 Å at the narrowest. SFs were about 100 Å wide with crossover distances ranging from 700 to 900 Å (Fig. 1c) . Western blotting showed that pathological tau bands of 60, 64, 68 and 72 kDa were present (Extended Data Fig. 1a ). These characteristics are like those described previously for PHFs and SFs from the brains of individuals with Alzheimer's disease 19 . Sarkosyl-insoluble material seeded the aggregation of fulllength human tau in cultured cells 20 .
PHFs and SFs are ultrastructural polymorphs
The sarkosyl-insoluble fraction of the patient's cerebral cortex was purified by differential centrifugation and gel filtration (Methods) with no disruption to the structures of PHFs and SFs (Extended Data Fig. 2a-c) .
The purified sarkosyl-insoluble fraction also seeded the aggregation of full-length human tau in cultured cells (Extended Data Fig. 2d ). The two types of filaments could be readily distinguished in cryo-EM images, and corresponding 3D reconstructions were calculated separately to overall resolutions of 3.4 and 3.5 Å, respectively (Extended Data Fig. 3 ), using helical reconstruction in RELION 21 . The maps showed clear side-chain densities (Fig. 2 ) and β -strands were well separated in the direction along the helical axis (Fig. 1e) , allowing us to propose stereochemically refined atomic models for the cores of PHFs and SFs (Methods).
Consistent with previous findings 6 , both PHFs and SFs are composed of two protofilaments with C-shaped subunits. Successive rungs of β -strands along a protofilament are related by helical symmetry with a rise of 4.7 Å and a twist of approximately − 1° in both PHFs and SFs. In PHFs, but not SFs, the two protofilaments are related by an approximate 2 1 screw symmetry. A clear pattern of side chain densities and various landmark features in the two maps revealed that the cores of both protofilaments in PHFs and SFs are composed of residues V 306 -F 378 (that is, all of R3 and R4) as well as 10 amino acids C-terminal to the repeats (Extended Data Fig. 4) . The protofilament cores of PHFs and SFs are similar (Extended Data Fig. 5 ), showing that they are ultrastructural polymorphs, reminiscent of fibrils formed by a peptide of transthyretin 22 . Additional, weaker densities appear at both the N-and C-terminal regions of the core (orange density in Fig. 2 ). The weaker densities suggest that these regions correspond to a mixture of peptides and/or a more dynamic or transiently occupied structure than the filament core. The weaker density at the N-terminal region can accommodate approximately 16 residues in a β -sheet-like conformation that may represent a mixture of the C termini of R1 and R2, which would result from the 3R and 4R alternative splicing products. This is consistent with our western blotting results, which indicated that all six brain tau isoforms were present in PHFs and SFs (Extended Data Fig. 1a ). Another region of additional density is found interacting with the sidechains of K 317 , T 319 and K 321 in both types of filaments (red arrows in Fig. 2 ). This density is strongest in SFs where it forms part of the protofilament interface, whereas in PHFs it occurs at the surfaces of both protofilaments.
Generality of PHF and SF structures
We used pronase treatment, mass spectrometry and antibody labelling to corroborate our model of a structured R3-R4 core with extending densities at the N and C termini. Pronase treatment has previously been shown to remove the fuzzy coat of PHFs and SFs, while leaving the structured core intact 7 . We confirmed that cryo-EM structures of the cores of PHFs and SFs did not change upon pronase treatment (Extended Data Fig. 6 ). Mass spectrometry of the pronase-treated igure 2 | Cross-sections of the PHF and SF cryo-EM structures. Cryo-EM density and atomic models of PHFs (a) and SFs (b). Overviews of the helical reconstructions (left) show the orientation of the crosssectional densities (right). Sharpened, high-resolution maps are shown in blue (PHFs) and green (SFs). Red arrows indicate additional densities in contact with K317 and K321. Unsharpened, 4.5 Å low-pass filtered density is shown in grey. Unsharpened density highlighted with an orange background is reminiscent of a less-ordered β -sheet and could accommodate an additional 16 amino acids, which would correspond to a mixture of residues 259-274 (R1) from 3R tau and residues 290-305 (R2) from 4R tau.
article reSearcH filaments showed that residues I 260 -R 406 of 3R and residues K 281 -R 406 of 4R tau are present in the structured core of the filaments, with R3-R4 (V 306 -R 406 ) being by far the most abundant species (Extended Data  Fig. 7a ). This finding is also in good agreement with peptides identified in earlier work 23, 24 , and a recent report on mass spectrometry of trypsin-treated PHFs and SFs from ten cases of Alzheimer's disease 25 .
In addition, to confirm that the whole of R2 is not part of the pronaseresistant core, we used anti-4R, an antibody raised against V 275 -C 291 of R2 (with D 279 ) 26 . Consistent with a pronase-resistant R3-R4 core, anti-4R detected both PHFs and SFs before, but not after, pronase treatment. By contrast, antibody MN423, which recognizes tau truncated at E 391 (ref. 24) , detected PHFs and SFs only after pronase treatment (Extended Data Fig. 7b ), as reported previously 19 . The model of an ordered R3-R4 core is also consistent with the observation that antibodies BR135 and TauC4, which recognize sequences inside R3 11 and R4 25 , respectively, do not label either PHFs or SFs, whereas they do label PHF tau on denaturing gels (Extended Data Fig. 1a ). Sequence analysis of the PHF core also showed the presence of R3-R4 of tau 24 . Thus, we propose that PHFs and SFs have a common core structure composed primarily of R3-R4, with a mixture of R1 and R2 directly preceding V 306 .
Structure of the common protofilament
The cores of PHFs and SFs are composed of eight β -sheets (β 1-8) that run along the length of the protofilament, adopting a C-shaped architecture. Each C consists of a β -helix region, where three β -sheets are arranged in a triangular fashion, and two regions with a cross-β architecture, where pairs of β -sheets pack anti-parallel to each other (Fig. 3a, b) . The formation of such a continuous β -strand architecture along the chain of an individual tau molecule (80% of residues are in a β -strand conformation occupying only 13.3% of the total φ /ψ space) is achieved by interspersing the β -strand regions with β -breaking prolines (P 312 , P 332 , P 364 ), β -turn glycines (G 323 , G 355 ) or β -arc residues (E 342 , D 348 ). The strain of having many twisted β -strand regions is further relieved by changes in the height of the chain along the helical axis, resulting in differences of up to 10 Å between the highest point in β 1 and the lowest point in the tip of the β -helix (Fig. 3c) . Thereby, an ordered, in-register, parallel hydrogen-bonding pattern is maintained throughout the protofilament structure. Additional hydrogen bonds that stabilize the protofilament are implied by the side chains of ladders of asparagines and glutamines.
Starting from the termini (Fig. 3d ), there is a heterotypic cross-β interface formed between β 1-2 and β 8. The N-terminal end of the ordered core is formed by the hexapeptide 306 VQIVYK 311 , which forms a complementary packing interface with residues 373-378 from the opposing β 8 by face-to-face packing of hydrophobic groups. Strands β 2 and β 8 pack against each other through a polar-zipper motif. Next, there is a right-angle turn accomplished through G 323 and G 326 on one side and a compact 364 PGGG 367 motif on the other side. It is possible that cysteine C 322 forms intra-sheet disulfide bonds, but we were unable to detect a regular pattern that would allow us to visualize density for such bonds in our helical reconstruction. A hydrophobic cluster of L 324 , I 326 and V 363 stabilizes the region immediately after the turn and the cross-β interface between β 3 and β 7 is further cemented by hydrogen bonds between the sidechains of H 328 and T 361 . Following β 3, residues 332 PGGG 335 adopt an extended β -spiral conformation. Finally, the two sides meet through a β -helix structure that is defined by three β -strands in R4 (β 4-6). Two-residue (E 342 , K 343 ) and three-residue ( 347 KDR 349 ) β -arc corners punctuate the triangular β -helix geometry, which is closed with a pivotal ~ 70° glycine conformation (G 355 ). Hydrophobic clustering, aliphatic stacking (V 339 , L 344 , V 350 and I 354 ) and aromatic stacking (F 346 ) stabilize the interior of the β -helix. Alternating charged residues between E 338 and R 349 on the solvent-exposed surface of the β -helix provide intramolecular charge compensation that offsets the repulsive effects of stacking sidechains with identical charges.
PHFs and SFs form different interfaces
The ultrastructural polymorphism between PHFs and SFs is due to differences in lateral contacts between the two protofilaments. In PHFs, the two protofilaments form identical structures that are related by helical symmetry, and the interface is formed by the anti-parallel stacking of residues 332 PGGGQ 336 (Fig. 4a) . The offset of half the β -strand distance along the helical axis results in a staggered packing of 333 GGG 335 from both protofilaments in PHFs. In particular, the glycine tripeptide adopts a characteristic polyglycine II, β -spiral structure 27 that forms a hydrogen-bonding pattern both within and between the two In SFs, the two protofilaments pack asymmetrically (Fig. 2b) . The weaker β -sheet-like density at the N-terminal end of the structured core is visible in only one of the protofilaments, as steric hindrance at the protofilament interface prevents the formation of a peripheral β -strand on the second protofilament. Although the β -helices of the two protofilaments appear to be in a similar chemical environment, the β -helix of the second protofilament is more disordered. The backbones of the two protofilaments are nearest each other between residues 321 KCGS 324 of the first and 313 VDLSK 317 of the second protofilament, where the protofilaments are packed against each other at approximately the same position along the helical axis (Fig. 4b) . However, these residues do not form inter-protofilament salt bridges or hydrogen bonds, nor does the interaction seem to be mediated by hydrophobic packing. Instead, the SF protofilament interface appears to be stabilized through the region of additional density that interacts with the side chains of K 317 , T 319 and K 321 of both protofilaments (red arrow, Fig. 2b ). These residues are part of the epitope of the Alz-50 and MC-1 antibodies 28 that is formed by two discontinuous portions of tau: 7 EFE 9 and 313 VDLSKVTSKC 322 . NMR experiments on heparininduced filaments of recombinant 4R tau confirm the interaction between the N terminus and residues 313-322 of the structured core 29 , which is strongly affected by ionic strength, and takes place mainly through intra-molecular interactions 29, 30 . Therefore, although we cannot preclude the role of other poly-anionic molecules, we speculate that the additional density corresponds to 7 EFE 9 , and that salt bridges between the negatively charged glutamates of the N terminus and the positively charged lysines of the core stabilize the interaction between the two protofilaments. A similar additional density also interacts with K 317 and K 321 in PHFs, where it does not contribute to the protofilament interface (red arrows, Fig. 2a) . Mutations directly preceding the 7 EFE 9 motif (that is, R5L 31 and R5H 32 ) have been observed in FTDP-17T.
Discussion
PHFs and SFs in Alzheimer's disease consist of an ordered core of pairs of protofilaments comprising residues 306-378, and disordered N-and C termini forming the fuzzy coat (Fig. 5) . The core forms a sufficient platform for the incorporation of both 3R and 4R tau into the growing filament. As we were unable to detect any order in the fuzzy coat, this heteromolecular addition may occur in a random manner. This would explain why PHFs and SFs are able to seed in vitro aggregation of recombinant samples containing only 3R tau, only 4R tau, or a mixture of 3R and 4R tau 13 . It may also explain why the intracerebral injection of PHFs and SFs from the brains of individuals with Alzheimer's disease leads to neuronal uptake, seeding and propagation in wild-type mice 13, 33 , as the tau 306-378 sequence is identical in humans and mice. The ordered core is probably necessary and sufficient for the seeded assembly of tau in Alzheimer's disease.
The protofilament core is composed of a combination of two structural motifs that are closely associated with amyloid and prion structures-cross-β packing 34 and β -helices 35 . This structure is markedly different from the conformation of tau bound to microtubules, where residues 269-284 and 300-312 adopt a hairpin conformation and the rest of the structure appears disordered by NMR 36 . The generic cross-β structure is widely accessible to peptides of varying lengths with unrelated amino acid sequences 37 . In Alzheimer's disease tau, in-register, anti-parallel β -sheet packing is mediated through a mixture of hydrophobic and polar interactions. The N-terminal part of the cross-β structure is formed by the hexapeptide 306 VQIVYK 311 , which is essential for the assembly of tau filaments 38, 39 . In contrast to homotypic interactions seen in microcrystals of isolated peptides 40 , the hexapeptide in Alzheimer's disease tau packs through a heterotypic, non-staggered interface with the opposing residues 373-378. The same packing interface is absent in the widely used K18 and K19 constructs 41 , which span three or four repeat domains of recombinantly expressed tau, and terminate at E 372 . Therefore, filaments made of K18 and K19 proteins cannot represent the complete core structure of PHFs and SFs derived from the brains of individuals with Alzheimer's disease, and care should be article reSearcH taken when extrapolating experimental results derived from the use of constructs ending before F 378 to tau aggregation in vivo 42 . In contrast to generic cross-β structures, β -helices are mediated by specific interactions that are not accessible to most amino acid sequences 43 . β -Helices can arise only from sequences with a specific pattern of hydrophobic residues on the inside, polar residues on the outside, and a pivotal β -arch-forming glycine at the end of the motif. An example of such β -helices is the prion-forming domain of HET-s from the filamentous fungus Podospora anserina 44 . The HET-s prions form a β -solenoid core, which is essential for infectivity, composed of two charge-complementary left-handed β -helical windings and a linker region. Despite having little sequence similarity, the β -helices in Alzheimer's disease tau and HET-s 218-289 (PDB-entry 2RNM 44 ) adopt a similar fold (Extended Data Fig. 8 ), raising the possibility that this motif may serve as a scaffold for prion-like, templated misfolding 45 . The β -helix in tau is closed by G 355 , which is located in the 353 KIGS 356 motif of R4 that comprises the potential phosphorylation site S 356 .
Knowledge of the atomic coordinates of tau filaments may be useful for the rational design of specific inhibitors of tau aggregation, as well as tracer compounds. Luminescent conjugated oligothiophenes (LCOs) bind to HET-s 218-289 through exposed lysine ladders on the surface of the β -solenoid 46 . Therefore, LCOs such as pentameric formyl thiophene acetic acid (pFTAA), a fluorescent dye that identifies neurofibrillary lesions in Alzheimer's disease brain sections 47 , may bind to aggregated tau in a similar way. The specific structure of the β -helix (or possibly the protofilament interface), as opposed to the more generic cross-β structure near the termini of the core, may also provide a binding site for PET ligands that show specific binding to Alzheimer's disease tau filaments, but not to tau filaments from other diseases, amyloid-β or α -synuclein 48 . Different molecular conformers of tau have been suggested to be related to specific neurodegenerative diseases. The structures presented here show how different protofilament packing interactions lead to ultrastructural polymorphism in tau filaments. Protein sequencing and mass-spectrometric analyses of tau filaments from various diseases have indicated that in Pick's disease, corticobasal degeneration and progressive supranuclear palsy, R1 and R2 are more resistant to trypsin digestion than in Alzheimer's disease 25 . This raises the possibility of another type of polymorphism, in which tau protofilaments may form from alternative combinations of the repeats (R1-R2 and R2-R3 from 4R tau, and R1-R3 from 3R tau) (Extended Data Fig. 9 ). Whether these hypothetical conformations exist in other tauopathies remains to be seen.
Conclusion
The cryo-EM structures of PHFs and SFs from the brain of an individual with Alzheimer's disease establish a basis for understanding the differences between molecular conformers of tau aggregates, and explain how different isoforms are incorporated into the filaments. Our results demonstrate that amyloid structures from human brain may be obtained by cryo-EM. This opens up new possibilities for studying the molecular mechanisms underlying a wide range of neurodegenerative diseases.
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MethOds
Extraction of tau filaments. Sarkosyl-insoluble material was extracted from grey matter of frontal and temporal cortex from the patient's brain, as described 19 . The resuspended pellet (10 μ l per g tissue) was further purified by 30-fold dilution in 10 mM Tris-HCl pH 7.4, 800 mM NaCl, 5 mM EDTA, 1 mM EGTA with a final concentration of 10% (w/v) sucrose, followed by centrifugation at 20,100g for 30 min at 4 °C. The pellet, containing large contaminants such as collagen, was discarded. The supernatant was centrifuged at 100,000g for 1 h at 4 °C. The pellet was resuspended in 20 mM Tris-HCl pH 7.4 containing 100 mM NaCl at 10 μ l per g tissue, and run over a Superose 6 Increase 3.2/300 column (GE Healthcare). PHFs and SFs eluted in the void volume, whereas ferritin, the main contaminant, and residual sucrose were retained. The filaments were concentrated using a Vivacon 500 centrifuge (Viva Products) at 3,000g and stored at 4 °C. Pronase treatment was carried out as described 19 .
Immunolabelling, histology and molecular genetics. Western blotting and immunogold EM were carried out as described 19 . For western blotting, samples were resolved on 4-20% or 10% Tris-glycine gels (Novex), and the primary antibodies were diluted in PBS plus 0.1% Tween 20 and 1% BSA as follows. BR133, BR134 and BR135 11 at 1:4,000; AT8 (Thermo; catalogue nr. MN1020) at 1:1,000; MC-1 28 at 1:10; HT7 (Thermo; catalogue nr. MN1000) at 1:2,500; anti-4R tau (Cosmo Bio; catalogue nr. CAC-TIP-4RT-P01) and TauC4 25 at 1:2,000; and MN423 24 at 1:500. For immunogold EM, primary antibodies were diluted as follows: BR133, BR134, BR135, AT8, anti-4R, TauC4 and MN423 at 1:50; MC-1 at 1:10. Neurohistology, immunohistochemistry, and molecular genetics were carried out as described 49 . For immunohistochemistry, the following antibody dilutions were used: RD3 (Millipore; catalogue nr. 05-803) at 1:3,000; anti-4R at 1:100; and AT8 and AT100 (Thermo; catalogue nr. MN1060) at 1:300. The brain sections were 8 μ m thick and were counterstained with haematoxylin. Seeded aggregation. Seeded aggregation in cells was carried out as described 50 . HEK 293T cells (European Collection of Authenticated Cell Cultures; ECACC) expressing full-length wild-type 0N4R tau were incubated for 3 h with the tau filament preparation used for cryo-EM diluted 1:1,000 in OptiMEM, followed by a change to complete medium (DMEM plus Glutamax and 10% fetal calf serum) and growth for 72 h. Cells were lysed in 10 mM Tris-HCl pH 7.4, 800 mM NaCl, 5 mM EDTA, 1 mM EGTA with a final concentration of 10% (w/v) sucrose by freeze-thaw, followed by sarkosyl extraction and western blotting. Band densities were calculated using ImageJ (NIH). Mass spectrometry. Purified tau filaments were disaggregated using 4 M guanidinium hydrochloride and digested with trypsin. The proteolytic peptides were injected for analysis by liquid chromatography with tandem mass spectrometry (LC-MS/MS) and identified by matching molecular mass to a peptide-fragment database. Pronase-treated tau filaments were processed in a similar way, but with an additional ultracentrifugation step to separate pronase-cleaved fuzzy coat regions from the core of the filament. In this case, the pellet containing the pronaseresistant core of the PHFs and SFs was disaggregated, trypsin digested and analysed by LC-MS/MS. Relative abundances of peptide fragments were quantified by measuring the areas under the readout curves from ion-mass chromatography. Cryo-electron microscopy. For cryo-EM, aliquots of 3 μ l of purified tau filaments at a concentration of 1 mg/ml were applied to glow-discharged holey carbon grids (Quantifoil Au R1.2/1.3, 300 mesh), blotted with filter paper to remove excess sample, and plunge-frozen in liquid ethane using an FEI Vitrobot Mark IV. Cryo-EM images were acquired on a Gatan K2-Summit detector in super-resolution counting mode on an FEI Titan Krios at 300 kV. A GIF-quantum energy filter (Gatan) was used with a slit width of 20 eV to remove inelastically scattered electrons. For full-length filaments (FL), fifty movie frames were recorded each with an exposure time of 200 ms using a dose rate of 1.2 electrons per Å 2 per frame for a total accumulated dose of 60 electrons per Å 2 at a pixel size of 1.04 Å on the specimen. For pronase-treated filaments (PT), twenty movie frames were recorded, each with an exposure time of 800 ms using a dose rate of 2.75 electrons per Å 2 per frame, resulting in a total accumulated dose of 55 electrons per Å 2 at a pixel size of 1.15 Å on the specimen. The final datasets are composed of 1,560 (FL) and 523 (PT) micrographs with defocus values in both datasets ranging from − 1.0 to − 3.0 μ m. Helical reconstruction. Similar procedures were applied to the FL and PT datasets. All super-resolution frames were corrected for gain reference, binned by a factor of 2, motion-corrected and dose-weighted using MOTIONCOR2 51 . Aligned, non-dose-weighted micrographs were then used to estimate the contrast transfer function (CTF) using Gctf 52 . All subsequent image-processing steps were performed using helical reconstruction methods in RELION 2.0 21 . Filaments were picked manually, and segments were extracted using a box size of 280 Å and an inter-box distance of ~ 10% (30 Å) of the box length. Reference-free 2D classification to identify homogeneous subsets was initially performed using a regularization value of T = 2. Selected class averages were repositioned onto the original micrographs according to the classification of individual segments to aid manual separation of the filaments into PHFs and SFs, which were then processed as separate datasets. An additional round of reference-free 2D classification was performed on the PHF and SF datasets to yield distinct classes for different views of the filaments.
Initial models for 3D classification were created from previously derived PHF and SF cross-sections 6 . Similar results could also be obtained from alternative initial models that were reconstructed from 2D class averages of segments that were extracted in a box that was large enough to almost comprise an entire pitch length. We first used 3D classification of the PHF and SF datasets with a regularization parameter of T = 4. These calculations yielded sub-nanometre (in the x-y plane only) reconstructions, in which individual β -sheets were clearly separated within the C-shaped subunits of both PHFs and SFs, but no structure was discernable along the (helical) z-axis. These results reflect the difficulty in reconstructing amyloid filaments, which have notoriously few layer lines visible in their power spectra between very low resolutions (~ 50 Å) and the distance between β -strands (4.7 Å).
We experimented with higher values of T in order to force the use of higher spatial frequencies in the regularized likelihood optimisation. 2D classifications with T values as high as 20 yielded 2D class averages with clearly discernable β -strand separation, but, possibly owing to overfitting, most of the segments were assigned to a single class representing a mixture of different views. More conservative regularizations with T = 8 yielded a more representative number of different 2D class averages that still showed clear β -strand separation.
We then selected those segments from the PHF and SF datasets that were assigned to 2D class averages with β -strand separation for subsequent 3D classification runs. For these calculations, we used a single class (K = 1); a T value of 20; and the previously obtained sub-nanometre PHF and SF reconstructions, lowpass filtered to 15 Å, as initial models. Imposing a helical rise of 4.7 Å and a helical twist of − 1° (as estimated from the crossover distances of filaments in the micrographs) led to 3D reconstructions of both PHFs and SFs in which β -strands were clearly resolved. At this point, we tested a range of different helical parameters. Optimizations of the helical twist all converged onto values of approximately − 1° per 4.7 Å rise. Helical rises of multiples of 4.7 Å all led to β -strand separation, but in agreement with the observed absence of layer lines between 50 and 4.7 Å (Extended Data Fig. 3d) we were unable to detect any repeating patterns among successive rungs of β -strands. Therefore, we decided to impose a helical rise of 4.7 Å, which resulted in a reconstruction in which all rungs of β -strands were identical. Finally, as we realized that PHFs consist of two identical protofilaments related by an approximate 2 1 screw, we imposed additional helical symmetry on the PHFs by using a rise of 4.7/2 Å and a twist of (360°− 1°)/2. This additional symmetry was absent in SFs, where the two protofilaments pack in an asymmetrical manner.
3D classifications with local optimization of the helical twist and rise were used for all four datasets to further select segments for high-resolution refinement. Although these classifications resulted in relatively small subsets of the initial datasets (Extended Data Table 1), reconstructions from much larger subsets gave similar reconstructions, albeit to lower resolutions, that were still in full agreement with our atomic interpretation (see below). This indicates that image classification did not select for a specific structure from a conformationally heterogeneous dataset, but instead was successful in distinguishing the better segments from datasets with images of varying quality, which is in line with observations in single-particle analysis. Image classification also did not separate variable twists of PHFs and SFs. Instead, RELION combines segments from filaments with variable twists into a single 3D reconstruction and reduces the corresponding blurring effects by only using the central part of an intermediate asymmetrical reconstruction for real-space helical symmetrisation 21 . For both PHFs and SFs, we used a 10% value for the corresponding helical_z_percentage parameter.
High-resolution refinements were performed using RELION's 3D autorefinement, during which both the helical twist and rise were optimized 21 . As initial models, we used 7 Å lowpass filtered maps of the PHF and SF from the 3D classification runs with K = 1. In some refinements, the two half-maps converged onto different translations along the helical axis. In such cases, it was necessary to halt the run and align the two half-maps outside RELION, before resuming the refinement. Final, overall resolution estimates were calculated from Fourier shell correlations at 0.143 between the two independently refined half-maps, using phase-randomization to correct for convolution effects of a generous, soft-edged solvent mask 53 . Local resolution estimates were obtained using the same phaserandomization procedure, but with a soft spherical mask that was moved over the entire map. Final PHF and SF reconstructions were sharpened using standard post-processing procedures in RELION, resulting in B-factors of approximately − 100 Å 2 on all maps (Extended Data Table 1 ), and helical symmetry was imposed on the post-processed maps using the relion_helix_toolbox program 21 . The PHF reconstructions from the FL and PT datasets were very similar, with overall resolution estimates of 3.4 and 3.5 Å, respectively (compare Fig. 2 and Extended Data Fig. 6 ). The SF map from the FL dataset had an overall resolution of 3.4 Å, article reSearcH but owing to a lower abundance of SFs after pronase treatment the corresponding map only reached 5.1 Å and β -strands were thus not separated.
Model building and refinement. The PHF and SF maps from the PT and FL datasets have complementary regions for model building. The β -helix motif at the tips of the C-shaped protofilaments is better ordered in PHFs than in SFs, whereas the N-and C-terminal ends of the protofilament cores are best ordered in the SF map from the FL dataset. Moreover, density for the cross-β structures near the termini of the PHFs is better defined in the PT reconstruction than in the FL reconstruction. Combined, the different maps allow unambiguous main-chain tracing of the atomic models ( Fig. 2; Extended Data Figs 4, 6) . Initial model building started by fitting the L-type β -helix from the magic-angle spinning NMR-derived structure of filaments of the prion-forming domain HET-s 218-289 (PDB-entry 2RNM) in the tip of the protofilaments of the PT PHF reconstruction. The sequence of only one of the four microtubule-binding repeats of tau had a sequence that was compatible with the observed density in both PHFs and SFs (Extended Data Fig. 4) . Using the β -helix region as a starting point, we then built the remainder of the Nand C-terminal regions by manually adding amino acids and targeted real-space refinement in COOT 54 .
Fourier-space refinement of the complete atomic model against the PHF and SF maps was performed in REFMAC 55 . A stack of three consecutive monomers from each of the protofilaments was refined to preserve nearest-neighbour interactions for the middle chain. Local symmetry restraints were imposed in REFMAC to keep all β -strand rungs identical. Since most of the structure adopts a β -strand conformation, hydrogen-bond restraints were imposed to preserve a parallel, in-register hydrogen-bonding pattern in earlier stages of the model building process. In addition, φ /ψ angle restraints were imposed for the polyglycine II region, 333 GGG 335 , and the three-residue β -arc, 347 KDR 349 . The dihedral angles for polyglycine II were taken from Crick and Rich's proposed fold 27 (φ = − 80, ψ = 150) and those for the three-residue β -arc from the crystal structure of PDB entry 1QRE 56 . Side-chain clashes were detected using MOLPROBITY 57 and corrected by iterative cycles of real-space refinement in COOT and Fourier-space refinement in REFMAC. Refinements of atomic models were performed for the FL and PT PHFs and for the FL SF. The refined model from the FL SF was rigid-body fitted article reSearcH article reSearcH extended data table 1 | Cryo-eM structure determination and model statistics for full-length (FL) and pronase-treated (Pt) filaments
